10/17/2025
Warning: Beige/white fentanyl
Through anecdotal reports and observations with on-site drug testing at Carepoint Consumption & Treatment Services, we would like to share the following information about possible side effects that could be associated with white/beige fentanyl.
Through on-site drug testing, we are able to share that the following substances were detected:
• Xylazine
• Nitazene
• Medetomidine
We have noticed reactions that include:
• Significant confusion after waking up including loss of time
• An increase in “tranquilizer-like” reactions
• Unusually difficult to rouse, sleep-like state but not in overdose as vital signs are stable (AKA “a heavy nod”)
Harm reduction recommendations when using substances:
• Try not to use alone.
• If you use alone, tell someone where you are. Ask them to check on you. The National Overdose Response Service (NORS) is available as a confidential overdose prevention hotline providing compassionate, nonjudgmental support for people who use drugs alone: 1.888.688.6677
• Use in small doses.
• Avoid mixing substances, if possible.
• Encourage use of Carepoint (Mon-Sun: 9:30 AM-8PM).
• Have naloxone ready and know how to respond to an overdose. Visit Ontario.ca/naloxone to learn more.
For more information, please contact Director of Harm Reduction Services, Megan Van Boheemen, at mvanboheemen@hivaidsconnection.ca or 226.377.8721.
Posted October 17, 2025. Please remove this notice by October 26, 2025 as the unregulated drug supply changes constantly. Visit hivaidsconnection.ca/advisory for more.